Catalent Expands Primary Packaging Capabilities at its Clinical Supply Facility in Shiga, Japan
Retrieved on:
Thursday, June 30, 2022 - 1:00am
SOMERSET, N.J., June 30, 2022 /PRNewswire-PRWeb/ -- Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has expanded its primary packaging capabilities at its clinical supply facility in Shiga, Japan, through the installation of a high-speed blister packaging line to complement its existing automated bottling line.
Key Points:
- SOMERSET, N.J., June 30, 2022 /PRNewswire-PRWeb/ -- Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has expanded its primary packaging capabilities at its clinical supply facility in Shiga, Japan, through the installation of a high-speed blister packaging line to complement its existing automated bottling line.
- The new blister packaging equipment is identical to that available across Catalent's clinical supply services network, offering maximum access and flexibility to customers undertaking this work globally.
- The 6,000-square-meter Shiga site opened in October 2021 to support customers locally and globally, providing flexible clinical supply solutions, including Catalent's FastChain demand-led supply, white glove handling and logistics.
- "The demand for primary packaging in Japan is very high, and customers are increasingly looking for integrated providers of clinical supply expertise and services," commented Roel de Nobel, Vice President and General Manager of Asia Pacific, Catalent Clinical Supply Services.